Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

doi:10.1186/gb-2007-8-1-r8

Download references

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

Monica C Panelli, Mitchell E Stashower, Herbert B Slade, Kina Smith, Christopher Norwood, Andrea Abati, Patricia Fetsch, Armando Filie, Shelley-Ann Walters, Calvin Astry, Eleonora Aricó, Yingdong Zhao, Silvia Selleri, Ena Wang and Francesco M Marincola^*

* Corresponding author: Francesco M Marincola Fmarincola@mail.cc.nih.gov

Genome Biology 2007, 8:R8 doi:10.1186/gb-2007-8-1-r8

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

Genome Biology

Viewing options

Associated material

Tools

Download references

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

Genome Biology

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Download references

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection